Actively Recruiting
MolecuLightDX Measurement Feature Clinical Validation
Led by MolecuLight Inc. · Updated on 2024-11-12
72
Participants Needed
2
Research Sites
14 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, single-arm, paired clinical evaluation of the MolecuLightDX device in the measurement of surface wounds in patients.
CONDITIONS
Official Title
MolecuLightDX Measurement Feature Clinical Validation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing to consent
- Willing to comply with all study procedures and availability for the duration of the study
- Male or female, aged over 22 years old
- Presented with diabetic foot ulcers, venous, arterial and pressure ulcers
- Wound size is greater than 0.5 cm2
- The wound has well-defined wound borders
You will not qualify if you...
- Circumferential wound
- Wound without clearly defined wound borders
- Wound located in a difficult to reach/measure location
- Any contra-indication to routine wound care and/or monitoring
- Wounds with a length greater than 18.5cm or a width greater than 13.5cm
- Tunneled or undermined wounds
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Mayer Institute
Hamilton, Ontario, Canada, L8R 2R3
Actively Recruiting
2
SHN Research Institute
Scarborough Village, Ontario, Canada, M1E 4B9
Not Yet Recruiting
Research Team
L
Laura Jones-Donaldson, PhD
CONTACT
H
Hanna Varonina, MSc, CCRP
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here